Eyepoint (EYPT)Paradigm Biocapital Advisors LP reduced its stake -252K shares

2.89M

Shares reported · -252K vs prior quarter

0.77%

Disclosed portfolio weight

$41.3M

Reported value

Holdings as of

Jun 30, 2026

Filed

Aug 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jun 18, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“EyePoint, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders on June 18, 2026 via live webcast (the “Annual Meeting”).”
2. Jul 13, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
3. Aug 5, 2026Company filing · Form 8-K · ResultsReported its results

What came next

1. Oct 7, 20265% stakeFederated Hermes, Inc. reported a passive stake (13G) of 8.0%

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Eyepoint

For Eyepoint, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EYPT page.

How this filing works

• SEC Form 13F

Other disclosures at Eyepoint

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRFeb 17, 2026

Everything OQRO holds on this company is on its EYPT page.